DHR
DHR
NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks
$227.33
+2.84 (+1.27%)
As of Sep 28, 9:31 PM ET ·
Financial Highlights (FY 2026)
Revenue
24.08B
Net Income
3.54B
Gross Margin
59.2%
Profit Margin
14.7%
Rev Growth
-2.7%
D/E Ratio
0.35
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.2% 59.2% 33.1% 33.1%
Operating Margin 19.2% 17.3% 22.8% 20.7%
Profit Margin 14.7% 14.0% 16.1% 14.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 24.08B 24.74B 64.73B 56.82B
Gross Profit 14.26B 14.65B 21.40B 18.79B
Operating Income 4.62B 4.27B 14.74B 11.75B
Net Income 3.54B 3.28B 10.42B 8.26B
Gross Margin 59.2% 59.2% 33.1% 33.1%
Operating Margin 19.2% 17.3% 22.8% 20.7%
Profit Margin 14.7% 14.0% 16.1% 14.5%
Rev Growth -2.7% -2.7% +18.7% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 20.45B 20.45B 69.79B 63.61B
Total Equity 58.33B 58.33B 119.38B 109.88B
D/E Ratio 0.35 0.35 0.58 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 5.35B 5.22B 20.74B 18.10B
Free Cash Flow — — 7.59B 7.26B